Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Apr;24(3):463-72. doi: 10.1016/s0278-5846(99)00112-8.

Abstract

1. The effects of acute administration of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on anxiety tested in the light/dark box were examined in albino male mice of the OF.1 strain. 2. Animals were evaluated in the light/dark test 30 min after injection of MDMA (1, 8, and 15 mg/kg, i.p) or saline. The following parameters were recorded (for 5 min); (a) number of exploratory rearings in the light and dark sections; (b) number of transitions between the lit and dark areas; (c) time spent in the light and dark areas; (d) latency of the initial movement from the light to the dark area, and (e) locomotor activity in light area. 3. MDMA (8 and 15 mg/kg) produced a significant reduction in exploratory activity (rearings and transitions), without decreasing motility, in comparison with saline-treated mice. However, time spent in lit/dark compartments was not significantly affected by the drug, which could be a consequence of the anti-exploratory properties of MDMA. 4. Overall, the behavioral profile found in the light/dark test indicates an anxiogenic-like activity of MDMA in mice. It is suggested, however, that animal models of anxiety which emphasize a social interaction could be more sensitive to the effects of this substance.

MeSH terms

  • Animals
  • Anxiety / drug therapy*
  • Anxiety / physiopathology
  • Disease Models, Animal
  • Exploratory Behavior
  • Hallucinogens / administration & dosage
  • Hallucinogens / pharmacology*
  • Light
  • Male
  • Mice
  • Motor Activity / drug effects
  • N-Methyl-3,4-methylenedioxyamphetamine / administration & dosage
  • N-Methyl-3,4-methylenedioxyamphetamine / pharmacology*

Substances

  • Hallucinogens
  • N-Methyl-3,4-methylenedioxyamphetamine